Categories: News

Zeki Data Launches Company Diagnostics to Expose Hidden Risks in Deep-Tech Firms

LONDON, Sept. 11, 2025 /PRNewswire/ — Zeki Data, the UK-based deep-tech intelligence firm, today unveiled Company Diagnostics, a breakthrough tool that reveals organisational health and hidden risks inside deep-tech companies—far beyond what financials or pitch decks disclose.

- Advertisement -

Drawing on Zeki’s global Talent IQ dataset, Company Diagnostics combines workforce, financial, and competitive signals to deliver a clear, predictive view of execution strength and scaling capability. Organizations may select to receive concise, expert-authored reports or structured datasets for integration into investment and strategy workflows.

- Advertisement -

In deep-tech, the real indicator of future innovation is hidden in the people, not just the numbers,” said Tom Hurd, CEO & Co-Founder of Zeki Data. “Company Diagnostics surfaces overlooked signals—talent alignment, technical depth, and execution readiness—so investors and strategists can make decisions with confidence.”

- Advertisement -

Zeki is tracking 1,500 companies—700 listed and 800 private—across 30+ countries, covering 3 million professionals in 4,500 domains and 100+ deep-tech verticals. Reports leverage 50+ proprietary Zeki-Score metrics, updated monthly with a time series back to 2010.

- Advertisement -

Key benefits include:

- Advertisement -
  • Spot hidden risks — Detect attrition hotspots, weak scaling, and talent misalignments before they impact performance.
  • Link talent to outcomes — Map technical depth, innovation pedigree, and peer recognition to financial and market positioning.
  • Decision-ready delivery — Choose rapid PDF snapshots or full data feeds for deeper analysis and benchmarking.

Use cases:

- Advertisement -
  • Venture capital and private equity — enhance diligence, benchmark scaling momentum, and anticipate execution risks.
  • Public market investors — integrate innovation signals, identify anomalous hiring, and generate alpha opportunities.
  • M&A teams — validate technical depth and de-risk acquisitions before closing.

Delivery options include monthly data subscriptions or one-off PDF reports, supporting both continuous monitoring and single, high-stakes decisions. To request a demo or learn more, visit zekidata.com.

- Advertisement -

About Zeki Data

- Advertisement -

Zeki Data is a UK-based deep-tech intelligence company providing the most accurate human-capital and organisational diagnostics available. Its proprietary datasets track millions of scientists, engineers, and innovators worldwide. Founded by Tom Hurd, a former senior intelligence leader, Zeki applies counter-terrorism-grade analytics to business, helping clients forecast innovation potential and manage risk. Learn more at zekidata.com.

- Advertisement -

Logo – https://mma.prnewswire.com/media/2771135/Zeki_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/zeki-data-launches-company-diagnostics-to-expose-hidden-risks-in-deep-tech-firms-302553897.html

- Advertisement -

Recent Posts

NYSE Content Update: ‘Patty’ at Center of Burger King’s New BK Assistant AI Solution

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 26, 2026…

1 hour ago

Hettich to Unveil New Innovations at Indiawood 2026, Showcasing Its Vision for Future Living and Workspaces

As industry leaders and design professionals gear up for Indiawood 2026, Hettich is preparing to…

1 hour ago

weBoost Named Winner in 2026 Merit Awards for Telecom & Wireless

ST. GEORGE, Utah, Feb. 26, 2026 (GLOBE NEWSWIRE) -- weBoost, the leader in cell signal…

2 hours ago

Ataccama Launches Agentic Data Observability to Extend Market-Leading Data Trust Platform

BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ataccama, the data trust company, today announced Agentic…

2 hours ago

Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf…

2 hours ago